Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

32,700.00ZAc
27 Aug 2015
Change (% chg)

-150.00c (-0.46%)
Prev Close
32,850.00c
Open
33,001.00c
Day's High
33,040.00c
Day's Low
32,400.00c
Volume
1,281,617
Avg. Vol
1,005,885
52-wk High
44,868.00c
52-wk Low
29,500.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a South Africa-based pharmaceutical company. The Company through its subsidiaries manufactures branded and generic pharmaceutical products as well as infant milk nutritionals and consumer healthcare products in selected territories, operating primarily in the healthcare industry. The Company... (more)

Overall

Beta: 0.50
Market Cap(Mil.): R149,910.50
Shares Outstanding(Mil.): 456.35
Dividend: 188.00
Yield (%): 0.57

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.07 33.75 34.00
EPS (TTM): 12.13 -- --
ROI: 8.38 15.10 14.57
ROE: 19.81 15.69 15.46
Search Stocks

BRIEF-Aspen Pharmacare sees to complete divestment of portfolio to Strides Australia by Aug 31

* Further announcement regarding the divestment of a portfolio of branded and generic products to Strides entities

11 Aug 2015

BRIEF-Aspen Pharma says talk of potential acquisition ongoing

* Aspen was engaged in discussions regarding possible acquisition of an infant nutritionals business

05 Aug 2015

BRIEF-Aspen Pharma says about 3.6 mln shares disposed of by Imithi Investments

* Lock-up period has now expired and imithi made a proportionate "in specie" distribution to them of Aspen shares on June 29, 2015

30 Jun 2015

UPDATE 1-India's Strides to buy Australia, Mauritius drug assets from Aspen for $300 mln

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd has agreed to buy businesses in Australia and Mauritius from South Africa's Aspen Pharmacare Holdings Ltd , paying $300 million to expand its footprint in markets set for brisk growth.

21 May 2015

India's Strides Arcolab to buy some Australia drug assets from Aspen Pharmacare

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd said on Thursday it has agreed to buy a generic drugs business in Australia from South Africa's Aspen Pharmacare Holdings Ltd for about A$380 million ($299.90 million).

21 May 2015

BRIEF-Aspen Pharmacare divests branded, generic products portfolio to Strides Pharma entities

* Aspen Global incorporated has entered into agreement with Strides Singapore for a consideration of about $92 million

21 May 2015

BRIEF-Aspen Pharmacare says in talks for possible acquisition of infant nutritionals business

* Is currently engaged in discussions regarding a possible acquisition of an infant nutritionals business Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

14 May 2015

BRIEF-Aspen Pharmacare sells a South African unit for about 1.6 bln rand

* Says deal for a consideration of approximately R1.6 billion

11 May 2015

GSK raises $853 million by halving stake in South African drugmaker

LONDON - GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million, following a long investment in the firm.

13 Mar 2015

BRIEF-GSK raises $853 mln via partial sale of Aspen Pharmacare shares

* GSK completes partial sale of Aspen Pharmacare Holdings Ltd shares - LSE announcement

13 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$25.00
Provider : Sadif Analytics Prime
$10.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks